Impact of Amending the Acetylcysteine Marketing Authorisation on Treatment of Paracetamol Overdose

In September 2012, the Medicines and Healthcare products Regulatory Agency (MHRA) substantially amended the Marketing Authorisation for acetylcysteine following an extensive review. The present study examined the impact of this license change on patterns of acetylcysteine use in patients presenting...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, G., Fatima, S. B., Shah, N., Kitching, G., Waring, W. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730223/
https://www.ncbi.nlm.nih.gov/pubmed/23956882
http://dx.doi.org/10.1155/2013/494357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730223/
https://www.ncbi.nlm.nih.gov/pubmed/23956882
http://dx.doi.org/10.1155/2013/494357

Ejemplares similares